| Drug Class |
Generic/Trade/ Company Names |
Indication |
Approving Regulatory Agency |
|
HIV and AIDS
|
Abacavir Sulfate
Ziagen
Glaxo Wellcome
|
- A nucleoside analogue reverse transcriptase inhibitor for the treatment of HIV and AIDS
|
HPB – Ottawa
|
|
Male Pattern Hair Loss
|
Minoxidil 2% Topical Solution
Taisho
|
|
Japanese Pharmaceutical and Medical Safety Bureau
|
|
Finasteride
Propecia
1mg Tablets Merck Sharp & Dohme
|
- An additional indication of male-pattern hair loss
|
UK MCA
|
|
Oncologic
Agents
|
Aldesleukin
Proleukin
Chiron
|
- An additional indication for treatment of malignant metastatic melanoma
|
HPB – Ottawa
|
|
Alitretinoin
Panretin
Gel 0.1% Ligand Pharmaceutical
|
- For topical treatment of cutaneous lesions in patients with AIDS related Kaposi’s Sarcoma
|
US FDA
HPB – Ottawa
|
|
Allovectin-7
Vical
|
- For treatment of invasive and metastatic melanoma
|
US FDA
(orphan drug status)
|
|
Bexarotene
Targretin
75mg Capsules Ligand Pharmaceuticals
|
- For treatment of cutaneous manifestations of cutaneous T-cell lymphoma (CTCL) in patients who are refractory to one or more prior systemic treatments for CTCL
|
US FDA
|
|
Denileukin Diftitox
Ontak
Ligand Pharmaceuticals
|
- For the treatment of CTCL
|
US FDA
(accelerated approval)
|
|
G-3139
Vical
|
- For the treatment of advanced malignant melanoma
|
US FDA
(fast-track designation)
|
|
Interferon Alpha-2a
Roferon-A
Hoffmann-La Roche
|
- For the adjuvant treatment of malignant melanoma patients who are at risk for relapse following resection
|
European Commission
(CPMP)
|
|
Melanoma Lysate
Melacine Therapeutic Vaccine
Schering-Plough
|
- For the treatment of late stage (IV) melanoma
|
HPB – Ottawa
|
|
Methoxsalen
Uvadex
Therakos
|
- For palliative treatment of the skin manifestations of CTCL that are unresponsive to other forms of therapy
|
US FDA
|
|
Osteoporosis
|
Alendronate
Fosamax
Merck
|
- For treatment of glucocorticoid induced osteoporosis in patients receiving glucocorticoids in a daily dosage equivalent to ≥ 7.5mg prednisone and who have low bone mineral density
|
US FDA
|
|
Pediculocides
|
Malathion
Ovide 0.5% Lotion
Medicis Pharmaceutical
|
- For treatment of head lice and their ova
|
For treatment of head lice and their ova US FDA
|
|
Pyrethrins/Piperonyl
Butoxide
Rid Aerosol Foam Mousse
Pfizer
|
- For treatment of head lice
|
US FDA
|
|
Photodynamic
Therapy
|
Aminolevulinic Acid
Levulan
Photodynamic Therapy DUSA Pharmaceuticals
|
- For treatment of actinic keratoses of the face and
scalp
|
US FDA
|
|
Topical
Anesthetics
|
Lidocaine 5%
Lidoderm
Patch Endo Pharmaceuticals
|
- For treatment of postherpetic neuralgia
|
US FDA
|
|
Lidocaine/Prilocaine
EMLA
Cream
Astra
|
- An additional indication for use in pediatric patients
|
US FDA
|
|
Vaginal Atrophy
|
Estradiol
Estradiol Transdermal System
Wyeth Ayerst Laboratories
|
- For the treatment of vulvar and vaginal atrophy
|
US FDA
|
